Sammanfattning
To date, the lack of age-appropriate medicines for many indications results in dose manipulation of commercially available dosage forms, commonly resulting in inaccurate doses. Various printing technologies have recently been explored in the pharmaceutical field due to the flexible and precise nature of the techniques. The aim of this study was, therefore, to compare the currently used method to produce patient-tailored warfarin doses at HUS Pharmacy in Finland with two innovative printing techniques. Dosage forms of various strengths (0.1, 0.5, 1, and 2 mg) were prepared utilizing semisolid extrusion 3D printing, inkjet printing and the established compounding procedure for oral powders in unit dose sachets (OPSs). Orodispersible films (ODFs) drug-loaded with warfarin were prepared by means of printing using hydroxypropylcellulose as a film-forming agent. The OPSs consisted of commercially available warfarin tablets and lactose monohydrate as a filler. The ODFs resulted in thin and flexible films showing acceptable ODF properties. Moreover, the printed ODFs displayed improved drug content compared to the established OPSs. All dosage forms were found to be stable over the one-month stability study and suitable for administration through a naso-gastric tube, thus, enabling administration to all possible patient groups in a hospital ward. This work demonstrates the potential of utilizing printing technologies for the production of on-demand patient-specific doses and further discusses the advantages and limitations of each method.
Originalspråk | Odefinierat/okänt |
---|---|
Sidor (från-till) | – |
Tidskrift | Pharmaceutics |
Volym | 11 |
Nummer | 7 |
DOI | |
Status | Publicerad - 2019 |
MoE-publikationstyp | A1 Tidskriftsartikel-refererad |
Nyckelord
- warfarin
- semisolid extrusion 3D printing
- 3D printing
- Personalized medicine
- oral powder
- pediatric
- orodispersible films
- on-demand manufacturing
- Inkjet printing
- hospital pharmacy